{"id":"W4281710573","doi":"10.1200/jco.2022.40.16_suppl.3107","title":"First-in-human (FIH) phase I study of the highly selective phosphoinositide 3-kinase inhibitor delta (PI3Kδ) inhibitor IOA-244 in patients with advanced cancer: Safety, activity, pharmacokinetic (PK), and pharmacodynamic (PD) results.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Pharmacodynamics; Pharmacokinetics; Melanoma; Immune system; Discontinuation; Cancer; Pharmacology; Oncology; Toxicity; Internal medicine; Immunology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00131959,0.001628596,0.001537941,0.0004000726,0.0004554583,0.0007775449,0.0007445638,0.001069064,0.004715311],"category_scores_gemma":[0.0006366094,0.0005315343,0.0009633367,0.0003407859,0.0009505271,0.0008368803,0.0004035642,0.002767525,0.0009089434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008845709,"about_ca_system_score_gemma":0.001446884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008746394,"about_ca_topic_score_gemma":0.001907317,"domain_scores_codex":[0.9996878,0.0001366049,0.00001052121,0.00004397336,0.00003178181,0.00008930633],"domain_scores_gemma":[0.9993924,0.0001065202,0.0001168062,0.00007059001,0.00002947933,0.0002843435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4787972,0.1718337,0.01550551,0.001109145,0.001234475,0.0007584692,0.0006527485,0.006287736,0.1334023,0.000570408,0.00930051,0.1805479],"study_design_scores_gemma":[0.184177,0.7804095,0.01799711,0.00002717333,0.0002761646,0.0004344409,0.00005858585,0.001122294,0.01100734,0.000253655,0.00420472,0.00003189957],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921902,0.001173555,0.00077306,0.0002607355,0.00005111947,0.002380906,0.001735341,0.00008932533,0.00134579],"genre_scores_gemma":[0.9836766,0.001283609,0.00274266,0.0007213944,0.0001823865,0.002949087,0.003060606,0.00004458221,0.005339149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004715311,"threshold_uncertainty_score":0.01577431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03137461808433421,"score_gpt":0.4020401450857913,"score_spread":0.3706655270014571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}